Literature DB >> 2164689

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.

H E Van Wart1, H Birkedal-Hansen.   

Abstract

The general applicability of the "cysteine-switch" activation mechanism to the members of the matrix metalloproteinase (MMP) gene family is examined here. All currently known members of the MMP gene family share the characteristic that they are synthesized in a latent, inactive, form. Recent evidence suggests that this latency in human fibroblast collagenase (HFC) is the result of formation of an intramolecular complex between the single cysteine residue in its propeptide domain and the essential zinc atom in the catalytic domain, a complex that blocks the active site. Latent HFC can be activated by multiple means, all of which effect the dissociation of the cysteine residue from the complex. This is referred to as the "cysteine-switch" mechanism of activation. The propeptide domain that contains the critical cysteine residue and the catalytic domain that contains the zinc-binding site are the only two domains common to all of the MMPs. The amino acid sequences surrounding both the critical cysteine residue and a region of the protein chains containing two of the putative histidine zinc-binding ligands are highly conserved in all of the MMPs. A survey of the literature shows that many of the individual MMPs can be activated by the multiple means observed for latent HFC. These observations support the view that the cysteine-switch mechanism is applicable to all members of this gene family. This mechanism is unprecedented in enzymology as far as we know and offers the opportunity for multiple modes of physiological activation of these important enzymes. Since conditions in different cells and tissues may match those necessary to effect one of these activation modes for a given MMP, this may offer metabolic flexibility in the control of MMP activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164689      PMCID: PMC54368          DOI: 10.1073/pnas.87.14.5578

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Electrochemical photolysis of water at a semiconductor electrode.

Authors:  A Fujishima; K Honda
Journal:  Nature       Date:  1972-07-07       Impact factor: 49.962

2.  The primary structure of Bacillus cereus neutral proteinase and comparison with thermolysin and Bacillus subtilis neutral proteinase.

Authors:  W Sidler; E Niederer; F Suter; H Zuber
Journal:  Biol Chem Hoppe Seyler       Date:  1986-07

3.  Nucleotide sequence of the pepN gene encoding aminopeptidase N of Escherichia coli.

Authors:  M Foglino; S Gharbi; A Lazdunski
Journal:  Gene       Date:  1986       Impact factor: 3.688

4.  The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.

Authors:  W G Stetler-Stevenson; H C Krutzsch; M P Wacher; I M Margulies; L A Liotta
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

5.  Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme.

Authors:  B Birkedal-Hansen; W G Moore; R E Taylor; A S Bhown; H Birkedal-Hansen
Journal:  Biochemistry       Date:  1988-09-06       Impact factor: 3.162

Review 6.  Zymogens of proteolytic enzymes.

Authors:  B Kassell; J Kay
Journal:  Science       Date:  1973-06-08       Impact factor: 47.728

7.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

8.  The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products.

Authors:  G A Grant; A Z Eisen; B L Marmer; W T Roswit; G I Goldberg
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

9.  Cloning and sequencing of Serratia protease gene.

Authors:  K Nakahama; K Yoshimura; R Marumoto; M Kikuchi; I S Lee; T Hase; H Matsubara
Journal:  Nucleic Acids Res       Date:  1986-07-25       Impact factor: 16.971

10.  Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms.

Authors:  V Knäuper; S Krämer; H Reinke; H Tschesche
Journal:  Eur J Biochem       Date:  1990-04-30
View more
  337 in total

1.  pH-regulated activation and release of a bacteria-associated phospholipase C during intracellular infection by Listeria monocytogenes.

Authors:  H Marquis; E J Hager
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

2.  Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28.

Authors:  L Howard; R A Maciewicz; C P Blobel
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

3.  Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.

Authors:  Y Jo; J Yeon; H J Kim; S T Lee
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 4.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 5.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

6.  Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures.

Authors:  Harald Frankowski; Yu-Huan Gu; Ji Hoe Heo; Richard Milner; Gregory J Del Zoppo
Journal:  Methods Mol Biol       Date:  2012

7.  Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine.

Authors:  R Gendron; D Grenier; T Sorsa; D Mayrand
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 8.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Bao-Yun Zhang; Jin Zhang; Qi Shi; Jing Wang; Chan Tian; Chen Gao; Kang Xiao; Ke Ren; Wei Zhou; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

10.  Mutations in the catalytic domain of human matrix metalloproteinase-1 (MMP-1) that allow for regulated activity through the use of Ca2+.

Authors:  Rudolph D Paladini; Ge Wei; Anirban Kundu; Qiping Zhao; Louis H Bookbinder; Gilbert A Keller; H Michael Shepard; Gregory I Frost
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.